Patrik Palacka

Phase II study of avelumab in multiple relapsed/refractory germ cell cancer

Michal Mego, Daniela Světlovská, Michal Chovanec et al. · Investigational New Drugs · 2019 · 85 citations

Medicine, Oncology, Pharmacology +10

Phase II study of everolimus in refractory testicular germ cell tumors

Michal Mego, Daniela Světlovská, Věra Miškovská et al. · Urologic Oncology Seminars and Original Investigations · 2015 · 52 citations

Medicine, Oncology, Urology +10

Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis

Michal Mego, Zuzana Syčová-Milá, Jana Obertová et al. · The Breast · 2011 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors

Michal Chovanec, Lucia Vasiľková, Lucia Setteyova et al. · The Oncologist · 2018 · 46 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16

Complementary therapy in diabetic patients with chronic complications: a pilot study.

Patrik Palacka, Jarmila Kucharská, Ján Murín et al. · PubMed · 2010 · 29 citations

Medicine, Endocrinology, Pharmacology +17